Jeff Kindler is retiring after four-and-a-half years as CEO of Pfizer, reports The Wall Street Journal. In a statement, Kindler said that his time there was "extremely exciting and rewarding" though also "extremely demanding" on him personally.
To read the full story....
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.